Male Hypogonadism
Reproductive Health
Male Hypogonadism is treated with 15 medications in our database, including Testosterone, Testosterone Cypionate, TESTOSTERONE, AZMIRO, testosterone cypionate, and 10 more. 14 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by AbbVie, Pfizer, Amneal, Lipocine, Glenmark and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Male Hypogonadism treatment below.
What help exists for Male Hypogonadism
13
drugs indexed
7
with copay cards
7
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Male Hypogonadism
13 totalTESTOSTERONE ENANTHATE
Testosterone Enanthate · Endo
🎟💙XTRENBO
Denosumab-qbde
AZMIRO
TESTOSTERONE CYPIONATE
🎟💙Aveed
testosterone undecanoate · Endo
Natesto nasal gel
testosterone · Acerus
TESTOSTERONE
Testosterone · AbbVie
Testone CIK
Testosterone Cypionate, Alcohol · Sircle
Turqoz
norgestrel and ethinyl estradiol · Glenmark
🎟💙Testopel
testosterone · Marius Pharmaceuticals
Testosterone Gel, 1%
AbbVie
🎟💙Tlando
testosterone undecanoate · Lipocine
🎟💙XYOSTED
testosterone enanthate · Antares
🎟💙TESTOSTERONE CYPIONATE
Testosterone Cypionate · Pfizer
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Male Hypogonadism drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Showing 10 of 17 PA rules for Male Hypogonadism drugs. View individual drug pages for complete PA detail.